These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22387070)

  • 1. Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population.
    Choi JM; Kim WC; Lyoo CH; Kang SY; Lee PH; Baik JS; Koh SB; Ma HI; Sohn YH; Lee MS; Kim YJ
    Neurosci Lett; 2012 Apr; 514(1):12-5. PubMed ID: 22387070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations for Gaucher disease confer high susceptibility to Parkinson disease.
    Mitsui J; Mizuta I; Toyoda A; Ashida R; Takahashi Y; Goto J; Fukuda Y; Date H; Iwata A; Yamamoto M; Hattori N; Murata M; Toda T; Tsuji S
    Arch Neurol; 2009 May; 66(5):571-6. PubMed ID: 19433656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece.
    Kalinderi K; Bostantjopoulou S; Paisan-Ruiz C; Katsarou Z; Hardy J; Fidani L
    Neurosci Lett; 2009 Mar; 452(2):87-9. PubMed ID: 19383421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan.
    Huang CL; Wu-Chou YH; Lai SC; Chang HC; Yeh TH; Weng YH; Chen RS; Huang YZ; Lu CS
    Eur J Neurol; 2011 Oct; 18(10):1227-32. PubMed ID: 21338444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease.
    Lesage S; Anheim M; Condroyer C; Pollak P; Durif F; Dupuits C; Viallet F; Lohmann E; Corvol JC; Honoré A; Rivaud S; Vidailhet M; Dürr A; Brice A;
    Hum Mol Genet; 2011 Jan; 20(1):202-10. PubMed ID: 20947659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease.
    Li Y; Sekine T; Funayama M; Li L; Yoshino H; Nishioka K; Tomiyama H; Hattori N
    Neurobiol Aging; 2014 Apr; 35(4):935.e3-8. PubMed ID: 24126159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocerebrosidase gene L444P mutation is a risk factor for Parkinson's disease in Chinese population.
    Sun QY; Guo JF; Wang L; Yu RH; Zuo X; Yao LY; Pan Q; Xia K; Tang BS
    Mov Disord; 2010 Jun; 25(8):1005-11. PubMed ID: 20131388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the glucocerebrosidase gene are responsible for Chinese patients with Parkinson's disease.
    Yu Z; Wang T; Xu J; Wang W; Wang G; Chen C; Zheng L; Pan L; Gong D; Li X; Qu H; Li F; Zhang B; Le W; Han F
    J Hum Genet; 2015 Feb; 60(2):85-90. PubMed ID: 25518742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocerebrosidase L444P mutation confers genetic risk for Parkinson's disease in central China.
    Wang Y; Liu L; Xiong J; Zhang X; Chen Z; Yu L; Chen C; Huang J; Zhang Z; Mohmed AA; Lin Z; Xiong N; Wang T
    Behav Brain Funct; 2012 Dec; 8():57. PubMed ID: 23227814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocerebrosidase mutations and the pathogenesis of Parkinson disease.
    Beavan MS; Schapira AH
    Ann Med; 2013 Dec; 45(8):511-21. PubMed ID: 24219755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.
    Alcalay RN; Dinur T; Quinn T; Sakanaka K; Levy O; Waters C; Fahn S; Dorovski T; Chung WK; Pauciulo M; Nichols W; Rana HQ; Balwani M; Bier L; Elstein D; Zimran A
    JAMA Neurol; 2014 Jun; 71(6):752-7. PubMed ID: 24756352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China.
    Mao XY; Burgunder JM; Zhang ZJ; An XK; Zhang JH; Yang Y; Li T; Wang YC; Chang XL; Peng R
    Neurosci Lett; 2010 Jan; 469(2):256-9. PubMed ID: 20004703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.
    Nichols WC; Pankratz N; Marek DK; Pauciulo MW; Elsaesser VE; Halter CA; Rudolph A; Wojcieszek J; Pfeiffer RF; Foroud T;
    Neurology; 2009 Jan; 72(4):310-6. PubMed ID: 18987351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease.
    Ziegler SG; Eblan MJ; Gutti U; Hruska KS; Stubblefield BK; Goker-Alpan O; LaMarca ME; Sidransky E
    Mol Genet Metab; 2007 Jun; 91(2):195-200. PubMed ID: 17462935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocerebrosidase mutations in Thai patients with Parkinson's disease.
    Pulkes T; Choubtum L; Chitphuk S; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
    Parkinsonism Relat Disord; 2014 Sep; 20(9):986-91. PubMed ID: 24997549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
    Neumann J; Bras J; Deas E; O'Sullivan SS; Parkkinen L; Lachmann RH; Li A; Holton J; Guerreiro R; Paudel R; Segarane B; Singleton A; Lees A; Hardy J; Houlden H; Revesz T; Wood NW
    Brain; 2009 Jul; 132(Pt 7):1783-94. PubMed ID: 19286695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese.
    Wu YR; Chen CM; Chao CY; Ro LS; Lyu RK; Chang KH; Lee-Chen GJ
    J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):977-9. PubMed ID: 17702778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.